Flares of Crohn's Disease - Symptoms, Causes, Treatment & Prevention

Overview

Crohn’s disease is a chronic, relapsing inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal (GI) tract—from the mouth to the anus—but most often involves the end of the small intestine (the ileum) and the beginning of the colon. A **flare** (or exacerbation) refers to a period when disease activity suddenly increases, producing new or worsening symptoms.

Key facts:

• Approximately 780,000–900,000 Americans live with Crohn’s disease, with an incidence of about 3–20 new cases per 100,000 people each year (CDC, 2022).
• Typical age of onset is 15–35 years, but children and older adults can be affected.
• Women and men are equally likely to develop the condition.
• People of Ashkenazi Jewish heritage have a 3–4‑fold higher risk, suggesting a strong genetic component.

Symptoms

During a flare, symptoms can range from mild to severe and may differ from a person’s baseline disease pattern. Common manifestations include:

Gastrointestinal

• Abdominal pain/cramping – often localized to the lower right quadrant (ileal disease) or the left side (colonic disease).
• Diarrhea – may be watery, contain mucus, or be bloody; urgency is frequent.
• Fatigue – secondary to inflammation, anemia, or medication side effects.
• Weight loss – loss of appetite and malabsorption of nutrients.
• Nausea & vomiting – especially if a stricture or obstruction develops.
• Fever – low‑grade fevers are common; high fevers can signal infection or perforation.

Extra‑intestinal (outside the gut)

• Joint pain (arthralgia) or arthritis, often affecting large joints.
• Skin lesions: erythema nodosum (tender red nodules), pyoderma gangrenosum (ulcerating wounds).
• Eye inflammation: uveitis or episcleritis.
• Oral ulcers or aphthous sores.
• Liver involvement: primary sclerosing cholangitis (PSC) – more common in ulcerative colitis but also seen in Crohn’s.

Red‑flag symptoms that may accompany a flare

• Severe, constant abdominal pain not relieved by usual medication.
• Persistent high fever (>38.5 °C/101.3 °F).
• Vomiting blood or passing black/tarry stools (melena).
• Sudden inability to pass gas or stool (possible obstruction).
• Rapid heart rate, dizziness, or fainting (signs of dehydration or severe anemia).

Causes and Risk Factors

The exact cause of Crohn’s disease is unknown, but flares result from a complex interplay of genetic susceptibility, immune system dysregulation, environmental triggers, and gut microbiome alterations.

Genetic factors

• More than 200 genetic loci have been linked to IBD; the strongest association is with the NOD2/CARD15 gene, which influences bacterial recognition.
• First‑degree relatives have a 10–15 % risk compared with <1 % in the general population.

Immune system abnormalities

• Overactive T‑cell responses produce excess inflammatory cytokines (TNF‑α, IL‑12, IL‑23) that damage the intestinal lining.

Environmental triggers

• Smoking – Increases risk of Crohn’s and worsens flares (CDC, 2021).
• Dietary factors – High intake of saturated fat and low fiber may aggravate inflammation, although direct causation is not proven.
• Infections – Certain bacterial (e.g., Mycobacterium avium subspecies paratuberculosis) and viral infections are hypothesized to precipitate flares.
• Stress – Psychological stress does not cause disease but can amplify symptom perception during a flare.

Medication‑related risks

• Non‑adherence to maintenance therapy (e.g., biologics) is a leading cause of flare recurrence.
• Use of NSAIDs (ibuprofen, naproxen) can irritate the gut lining and trigger flares in susceptible individuals.

Diagnosis

Diagnosing a flare involves confirming active inflammation and excluding other causes of similar symptoms (infection, medication side effects, etc.). The work‑up typically includes:

Clinical assessment

• Detailed history of symptom pattern, medication adherence, and recent exposures.
• Physical exam focusing on abdominal tenderness, masses, and extra‑intestinal signs.

Laboratory tests

• Complete blood count (CBC) – anemia, leukocytosis.
• C‑reactive protein (CRP) and erythrocyte sedimentation rate (ESR) – markers of systemic inflammation.
• Fecal calprotectin – distinguishes inflammatory from functional diarrhea; values >250 µg/g often indicate active disease.
• Stool cultures and Clostridioides difficile PCR to rule out infection.

Imaging & endoscopy

• Colonoscopy with ileoscopy – gold standard; allows direct visualization, biopsy for histology, and assessment of mucosal healing.
• Magnetic resonance enterography (MRE) or CT enterography – evaluates small‑bowel involvement, strictures, fistulas, and abscesses without invasive scope.
• Ultrasound (especially in Europe) – useful for detecting bowel wall thickening and Doppler hyperemia during a flare.

Biopsy

Histologic examination can confirm chronic granulomatous inflammation characteristic of Crohn’s and exclude infection or malignancy.

Treatment Options

Therapeutic goals are to induce remission (short‑term) and maintain remission (long‑term), while minimizing steroid exposure and preserving quality of life.

Medications

• Systemic corticosteroids (prednisone, methylprednisolone) – rapid symptom control for moderate‑to‑severe flares. Tapered over weeks to avoid dependence.
• Bud***:> Topical steroids (bud‑ orb) – delivery via enema or suppository for distal colonic disease.
• Immunomodulators – azathioprine, 6‑mercaptopurine, methotrexate; used for steroid‑sparing maintenance, take 8–12 weeks to become effective.
• Biologic agents
  • Anti‑TNF α: infliximab, adalimumab, certolizumab.
  • Anti‑integrin: vedolizumab (gut‑selective).
  • IL‑12/23 inhibitor: ustekinumab.
  These are the mainstay for moderate‑to‑severe disease and for patients with fistulizing complications.
• JAK inhibitors – upadacitinib, tofacitinib (off‑label for Crohn’s) for refractory disease.
• Antibiotics – ciprofloxacin or metronidazole for perianal disease or when bacterial overgrowth is suspected.
• Antidiarrheals – loperamide may be used cautiously; avoid in presence of high fever or toxic megacolon.

Procedures & Surgical Options

• Endoscopic balloon dilation – for short, accessible strictures.
• Percutaneous drainage of abscesses (often combined with antibiotics).
• Surgical resection – indicated for refractory strictures, perforation, or severe bleeding. Resection is not curative; disease can recur at a different site.
• Seton placement – for complex perianal fistulas, often combined with biologic therapy.

Lifestyle & Dietary Adjustments

• Tailored diet – low‑residue, low‑fat, and adequate protein during acute flares; later, a balanced diet rich in soluble fiber may help maintain remission.
• Hydration – replace fluids lost through diarrhea; oral rehydration solutions are useful.
• Smoking cessation – the single most effective modifiable risk factor (CDC, 2021).
• Stress‑management techniques – mindfulness, CBT, yoga; evidence shows modest symptom reduction.
• Probiotics & prebiotics – limited data; some patients benefit from VSL#3 or fermented foods.

Living with Flares of Crohn’s Disease

Effective self‑management can shorten flare duration and reduce complications.

Daily monitoring

• Keep a symptom diary (pain scores, stool frequency, blood, fatigue) to spot trends early.
• Regularly test fecal calprotectin at home (available kits) to gauge inflammation.
• Track medication adherence with a pill organizer or smartphone reminder.

Nutrition tips

• During a flare, opt for soft, low‑fiber foods (e.g., bananas, boiled carrots, white rice, plain yogurt).
• Avoid high‑lactose dairy, spicy foods, nuts, and seeds that can irritate the gut.
• Consider a multivitamin with iron, B12, vitamin D, and calcium if malabsorption is present.

Physical activity

• Gentle walking or low‑impact exercises improve bowel motility and mood; avoid high‑intensity workouts during severe pain.

Psychosocial support

• Join a Crohn’s support group (online or local) to share coping strategies.
• Seek counseling if anxiety or depression develops; rates of mood disorders are ~30 % in IBD patients (NIH, 2020).

Medication safety

• Never stop biologics or immunomodulators abruptly without physician guidance.
• Report new infections promptly—immunosuppressed patients may have atypical presentations.

Prevention

While a flare cannot be completely prevented, the following measures lower its frequency and severity:

• Maintain strict adherence to prescribed maintenance therapy (biologics, immunomodulators).
• Quit smoking; seek nicotine‑replacement therapy or counseling if needed.
• Limit NSAID use; choose acetaminophen for pain/fever when appropriate.
• Adopt a Mediterranean‑style diet rich in omega‑3 fatty acids, fruits, vegetables, and whole grains—observational studies suggest a modest reduction in flare rates.
• Stay up-to-date on vaccinations (influenza, COVID‑19, pneumococcal, hepatitis B) to prevent infection‑triggered flares.
• Regular follow‑up with a gastroenterologist for lab monitoring and early endoscopic assessment.

Complications

If flares are inadequately treated, several serious complications can arise:

• Intestinal obstruction – from strictures or fibrotic scarring; may require dilation or surgery.
• Fistulas – abnormal connections between bowel loops or to the skin, bladder, vagina, or perianal region.
• Abscess formation – localized pus collections needing drainage and antibiotics.
• Toxic megacolon – rapid colonic dilation with systemic toxicity; surgical emergency.
• Perforation – leads to peritonitis and sepsis.
• Malnutrition & anemia – chronic blood loss, malabsorption of iron, B12, and folate.
• Colorectal cancer – risk increases after >8–10 years of disease involving the colon; recommended colonoscopic surveillance every 1–3 years (American Cancer Society, 2023).
• Bone loss – glucocorticoid exposure and vitamin D deficiency increase osteoporosis risk.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:

• Severe, constant abdominal pain that does not improve with prescribed medication.
• High fever (>38.5 °C or 101.3 °F) accompanied by chills.
• Vomiting blood or passing black, tarry stools (possible gastrointestinal bleeding).
• Sudden inability to pass gas or stool, indicating a possible bowel obstruction.
• Rapid heart rate (>120 bpm), dizziness, fainting, or signs of severe dehydration.
• Swelling of the abdomen, severe tenderness, or a rigid “board‑like” abdomen (possible perforation).
• Worsening shortness of breath or chest pain while on biologic therapy (rare but may signal infection).

Prompt medical attention can prevent life‑threatening complications and improve outcomes.

References

• Mayo Clinic. “Crohn’s disease.” Updated 2023. https://www.mayoclinic.org/diseases-conditions/crohns-disease
• Centers for Disease Control and Prevention (CDC). “Inflammatory Bowel Disease (IBD) Surveillance.” 2022. https://www.cdc.gov/ibd
• National Institutes of Health (NIH). “Crohn’s Disease Fact Sheet.” 2020. https://www.niddk.nih.gov/health-information/digestive-diseases/crohns-disease
• World Health Organization (WHO). “Guidelines for the Management of IBD.” 2021. https://www.who.int/publications/i/item/guide-management-ibd
• Cleveland Clinic. “Crohn’s Disease Treatment Options.” 2023. https://my.clevelandclinic.org/health/diseases/11592-crohns-disease
• American Cancer Society. “Colorectal Cancer Risk in IBD.” 2023. https://www.cancer.org/cancer/colon-rectal-cancer/causes-risks-prevention/risk-factors.html